SightfileU.S. market data from official filings

MIRUM PHARMACEUTICALS INC (MIRM)

Name: MIRUM PHARMACEUTICALS INC (MIRM) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001759425 · EDGAR filings · Updated 2026-07-08

MIRUM PHARMACEUTICALS INC (MIRM) has reported institutional ownership of 111.9%, with 311 institutional managers holding positions valued at $6.29B per the latest 13F reporting period.

Institutional ownership

111.9%

Institutional managers

311

Reported 13F value

$6.29B

Insider activity

87 trans.

−$22.5M net selling

Latest updates

2026-07-08 — Insider transaction reported (Form 4)
2026-07-08 — Insider transaction reported (Form 4)
2026-07-06 — Notice of proposed sale filed (Form 144)
2026-07-06 — Notice of proposed sale filed (Form 144)
2026-07-02 — Insider transaction reported (Form 4)
2026-07-01 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MIRUM PHARMACEUTICALS INC has 311 institutional holders and institutional ownership of 111.9%.

Insider activity

Insiders reported 87 transactions (1 buys, 40 sells) across 12 reporting insiders, with a net reported value of −$22.5M.

Related companies

PTC THERAPEUTICS INC (PTCT) · RHYTHM PHARMACEUTICALS INC COM (RYTM) · AXSOME THERAPEUTICS INC. (AXSM) · GLAUKOS CORP (GKOS) · ALKERMES PLC (ALKS) · CG ONCOLOGY INC (CGON)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.